Merck, Moderna claim encouraging melanoma vaccine trial results
- Posted on August 19, 2026
- By South China Morning Post
- 0 Views
- 1 min read
In brief
Generating AI summary…
Merck, Moderna claim encouraging melanoma vaccine trial results
The vaccine, intismeran autogene, showed ‘meaningful improvements’ for skin cancer patients when used with Merck’s Keytruda treatment, the firms say.
